The company is cited for using unapproved visual-inspection methods for finished parenteral drugs and conducting inadequate visual inspections.
Biopharma News
Advertisement
Modular containment room at Belfast facility allows studies of biologics and vaccines.
Program aims to develop a novel oral treatment.
Advertisement
Advertisement